Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 6:57 PM ET | Feedback | Site Changes | Help
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
View All Commentary (GSK)
Recs
ant108 (< 20) Submitted: 6/14/07 4:00 AM : Start Price: $48.76 GSK Score: 20.83
Classic 'crisis' value play. Recent bad news over pipeline drug has driven the price down to artificially low price. Current PE and yield at very low levels compared to historical. Short term value play, divi provides nice cushion while you wait for the re-rating.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK